Proteomics analysis of the actions of grape seed extract in rat brain: technological and biological implications for the study of the actions of psychoactive compounds.

Grape seed extract (GSE) is a commonly available dietary supplement taken for the anti-oxidant activity that's attributed to its proanthocyanidin (oligomers of monomeric polyphenols) content. Similar polyphenol-enriched preparations from blueberries and soy have shown protection against ovariectomy-induced or age-related cognitive deficits, suggesting that the molecular changes induced by these polyphenol preparations correlated with behavioral benefit. We hypothesized that ingestion of polyphenol-enriched preparations such as GSE would be manifested as protein changes that would be consistent with neuroprotection. Proteomics technology, namely 2D gel electrophoresis and mass spectrometry, identified quantitative changes in specific proteins induced in adult rat brain following ingestion of a powdered preparation of GSE. As recently reported [Deshane, J., Chaves, L., Sarikonda, K.V., Isbell, S., Wilson, L., Kirk, M., Grubbs, C., Barnes, S., Meleth, S. and Kim, H., 2004. Proteomics analysis of rat brain protein modulations by grape seed extract. Journal of Agricultural and Food Chemistry 52, 7872-7883.], the direction of change for the majority of the affected proteins was opposite to the direction the proteins were changed in either Alzheimer disease or in transgenic mouse models of dementia. A conservative conclusion is that GSE has neuroprotective activity, by affecting specific proteins in particular ways. In this chapter, elements of proteomics-type analysis are discussed that demonstrate the power of the technology to enable discovery of proteins involved in the response of the brain to a stimulus whether it be a dietary supplement, or a psychoactive drug. The fact that GSE affects proteins implicated in cognitive disorders suggests moreover that GSE may have impact on the actions of psychoactive drugs by maintaining an overall viability of the nervous system.

[1]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[2]  Yuan Luo,et al.  Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. , 2003, Journal of Alzheimer's disease : JAD.

[3]  R. Faull,et al.  Proteomic analysis of the brain in Alzheimer’s disease: Molecular phenotype of a complex disease process , 2001, Proteomics.

[4]  P. Kenemans,et al.  Postmenopausal hormone therapy: impact on menopause-related symptoms, chronic disease and quality of life. , 2004, Drugs.

[5]  T. Koga,et al.  Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. , 1999, Atherosclerosis.

[6]  F. Vandesande,et al.  Differential expression of brain proteins in glycogen synthase kinase‐3 transgenic mice: A proteomics point of view , 2002, Proteomics.

[7]  H. Geerts,et al.  Proteomics analysis of the neurodegeneration in the brain of tau transgenic mice , 2002, Proteomics.

[8]  S. Barnes,et al.  Proteomics analysis of rat brain protein modulations by grape seed extract. , 2004, Journal of agricultural and food chemistry.

[9]  C. Sen,et al.  Cellular Protection with Proanthocyanidins Derived from Grape Seeds , 2002, Annals of the New York Academy of Sciences.

[10]  S. Shimohama,et al.  Proteomic Profiling and Neurodegeneration in Alzheimer's Disease , 2002, Neurochemical Research.

[11]  J. Vaya,et al.  The relation between the chemical structure of flavonoids and their estrogen-like activities. , 2004, Current medicinal chemistry.

[12]  T. Kanda,et al.  Induction of apoptosis by three types of procyanidin isolated from apple (Rosaceae Malus pumila) in human stomach cancer KATO III cells. , 2004, International journal of molecular medicine.

[13]  Jun Wang,et al.  Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. , 2002, The Journal of nutrition.

[14]  S. Apers,et al.  Proanthocyanidins in health care: current and new trends. , 2004, Current medicinal chemistry.